Updated:
ReMy Ventures
ReMy Ventures is a Des Moines-based early-stage private equity firm that invests at the seed stage across undisclosed sectors.
ReMy Ventures
ReMy Ventures is a healthcare data and technology-focused company founded in 2023 in Des Moines, Iowa. It has made one investment, in Starling Medical, as part of a Seed VC round on February 1, 2023.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Des Moines
Corporate office
Des Moines, IA, United States
Frequently asked questions
Who runs investment decisions at ReMy Ventures?
ReMy Ventures has not publicly disclosed its named principals or investment committee structure. No individuals are listed on the firm's website or in regulatory filings that identify decision-makers for capital allocation. This opacity is unusual for an early-stage manager, where founder track records typically serve as a primary diligence signal for limited partners.
How does ReMy Ventures source proprietary deal flow?
Given its Des Moines base, the firm likely draws from networks outside conventional venture corridors—Midwest university spinouts, agricultural technology founders, and financial services talent pools anchored by the region's insurance and banking sectors. Without public portfolio disclosures or a visible brand presence, deal flow likely depends on direct founder relationships rather than inbound referral volume.
What investment stages does ReMy Ventures typically target?
ReMy Ventures focuses on early-stage seed investments, the first round of institutional capital a company receives. Seed checks are typically deployed pre-revenue or at minimal scale, often alongside angel investors and before a company has proven product-market fit. The firm does not publicly indicate participation in later-stage rounds, growth equity, or buyout transactions.
Does ReMy Ventures participate in fund commitments or only direct deals?
Available public information describes ReMy Ventures as a private equity firm making early-stage investments, which implies direct company-level positions. There is no public evidence of the firm acting as a limited partner in third-party funds or operating a fund-of-funds allocation alongside its direct investment activity.
Where does the underlying capital come from?
The source of ReMy Ventures' capital has not been publicly disclosed. The firm is structured as an asset manager rather than a single-family office, which typically indicates pooled third-party capital from external limited partners rather than a single wealth origin. However, without named LP disclosures or regulatory filings clarifying the investor base, the composition of fund commitments remains private.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: